NSE ScannerComparison · NSE · data 2026-11-01
Lenskart Solutions Limited vs Molbio Diagnostics Limited
In plain words
Size: Lenskart Solutions Limited is about 8 times the market value of Molbio Diagnostics Limited.
Return on equity: Molbio Diagnostics Limited 13.8% vs Lenskart Solutions Limited 6.7%.
Debt to equity: Lenskart Solutions Limited 0.35 vs Molbio Diagnostics Limited 0.3.
Differences in the numbers, not a recommendation of either stock.
Side by side
| LENSKART | MOLBIO | |
|---|---|---|
| Price | ₹678.2 | ₹1,274 |
| Market cap | ₹1,17,960 cr | ₹14,689 cr |
| P/E | 179 | — |
| P/B | — | — |
| ROE | 6.7% | 13.8% |
| ROCE | 7.8% | 19.2% |
| Debt / equity | 0.35 | 0.3 |
| Operating margin | 9.2% | — |
| Dividend yield | 0.00% | 0.00% |
| Sales growth, 3 years (yearly) | 33.5% | 58.1% |
| Profit growth, 3 years (yearly) | — | — |
| 1-year return | 68.7% | 57.9% |
| Revenue, last 12 months | ₹9,634 cr | — |
| Net profit, last 12 months | ₹655 cr | — |
| Latest quarter | Jun 2026 | Jun 2026 |
| Quarter net profit | ₹222 cr | ₹59 cr |
| Quarter profit vs a year earlier | — | — |
| Promoter holding | 17.52% | 41.29% |
| Health check | Average (6/10) | Strong (8.3/10) |
Common questions
Which earns a higher return on equity?
Molbio Diagnostics Limited (13.8% against 6.7%).
Which carries more debt?
Lenskart Solutions Limited has the higher debt-to-equity ratio (0.35 against 0.3).